Literature DB >> 3431293

[Cardiocirculatory failure--new therapeutic possibilities].

E Erdmann1.   

Abstract

The different causes of cardiogenic shock and circulatory failure have to be treated according to their aetiology and the state of the patient. Recent experience with percutaneous transfemoral valvuloplasty in 33 patients with aortic stenosis and angioplasty of occluded coronary arteries in acute postoperative myocardial infarction in 13 patients is in favour of active treatment of patients before and even after circulatory failure has occurred. Aortic valvuloplasty was performed successfully and with minor complications in 5 patients in cardiogenic shock.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3431293     DOI: 10.1007/BF01297792

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  5 in total

1.  Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?

Authors:  A Cribier; T Savin; N Saoudi; P Rocha; J Berland; B Letac
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

2.  [Percutaneous transfemoral valvuloplasty of calcified and non-calcified aortic valves].

Authors:  E Erdmann; B Höfling
Journal:  Dtsch Med Wochenschr       Date:  1987-07-03       Impact factor: 0.628

3.  Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction.

Authors:  G O Hartzler; B D Rutherford; D R McConahay; W L Johnson; B D McCallister; G M Gura; R C Conn; J E Crockett
Journal:  Am Heart J       Date:  1983-11       Impact factor: 4.749

4.  Percutaneous double-balloon mitral valvotomy for rheumatic mitral-valve stenosis.

Authors:  M Al Zaibag; P A Ribeiro; S Al Kasab; M R Al Fagih
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

5.  Percutaneous transluminal balloon pulmonary valvuloplasty for the relief of pulmonary valve stenosis with special reference to double-balloon technique.

Authors:  M A Ali Khan; S A Yousef; C E Mullins
Journal:  Am Heart J       Date:  1986-07       Impact factor: 4.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.